Biocon submits press release

05 Nov 2019 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Biocon has informed about submission of the press release titled ‘Biocons Biologics Drug Products Facility in Bengaluru Receives EIR from US FDA’. 

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

352.55 -12.60 (-3.45%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.65
Dr. Reddys Lab 1217.60
Cipla 1193.40
Zydus Lifesciences 864.25
Lupin 2276.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×